产品名称:感觉神经性耳聋常染色体隐性遗传61抗体,Anti-Slc26a5抗体
中文名称:感觉神经性耳聋常染色体隐性遗传61抗体
英文名称:Anti-Slc26a5
产品编号:byk-2660R
产品规格:0.1ml/0.2ml
产品用途:科研实验
性 状: Lyophilized or Liquid
浓 度: 1mg/1ml
亚 型: IgG
贮 存: 贮存于-20℃.
相关标记: HRP Biotin Gold RBITC AP FITC Cy3 Cy5 Cy5.5 Cy7 PE PE-Cy3 PE-CY5 PE-CY5.5 PE-CY7 APC Alexa Fluor 350 Alexa Fluor 488 Alexa Fluor 555 Alexa Fluor 647
我公司拥有领先的细胞服务技术,先进的仪器设备和专业的ELISA检测试剂盒、生物索标记、荧光索标记、酶标记等,广泛用于多种分析研究与技术测定。欢迎来电咨询,我们将竭诚为你服务!
感觉神经性耳聋常染色体隐性遗传61抗体,Anti-Slc26a5抗体 相关产品:
单核细胞趋化蛋白5抗体 Anti-CCL12/MCP5
膜粘连蛋白13抗体 Anti-Annexin A13
Rho GTP酶激活蛋白13抗体 Anti-SRGAP1
嗜酸粒细胞趋化蛋白抗体 Anti-CCL11/Eotaxin 1
锌指蛋白744抗体 Anti-ANKZF1/ZNF744
嗜酸粒细胞趋化蛋白CCL6抗体 Anti-CCL6/C10
神经肿瘤Nova1抗原抗体 Anti-Nova1
T细胞特异性趋化因子抗体 Anti-CCL5/RANTES
巨噬细胞炎性蛋白1β抗体 Anti-CCL4/MIP-1 Beta
锚定蛋白重复结构域蛋白激酶ANKK1抗体 Anti-ANKK1
巨噬细胞炎性蛋白1α抗体 Anti-CCL3/MIP 1α
遗传性失明相关蛋白AIPL1抗体 Anti-AIPL1
真核翻译起始因子2C2抗体 Anti-eIF2C2/Ago2
嗜酸粒细胞趋化蛋白CCL1抗体 Anti-CCL1/TCA3/I-309
瓜氨酸环肽抗体 Anti-CCP
卡尔曼综合症基因1抗体 Anti-KAL1
多重表皮生长因子样蛋白4抗体 Anti-Slit1/MEGF4
克拉拉细胞蛋白抗体 Anti-CC16/CCSP
胆囊收缩素8抗体 Anti-CCK8
磷酸化CBX5抗体 Anti-Phospho-CBX5(Tyr37)
抗体规律
(1)初次反应产生抗体:当抗原一次进入机体时,需经一定的潜伏期才能产生抗体,且抗体产生的量也不多,在体内维持的时间也较短。
(2)再次反应产生抗体:当相同抗原第二次进入机体后,开始时,由于原有抗体中的一部分与再次进入的抗原结合,可使原有抗体量略为降低。随后,抗体效价迅速大量增加,可比初次反应产生的多几倍到几十倍,在体内留存的时间亦较长。
(3)回忆反应产生抗体:由抗原刺激机体产生的抗体,经过一定时间后可逐渐消失。此时若再次接触抗原,可使已消失的抗体快速上升。如再次刺激机体的抗原与初次相同,则称为特异性回忆反应;若与初次反应不同,则称为非特异性回忆反应。非特异性回忆反应引起的抗体的上升是暂时性的,短时间内即很快下降。
感觉神经性耳聋常染色体隐性遗传61抗体,Anti-Slc26a5抗体 产品详情:
SLC26A5 (Solute carrier family 26, member 5) is specifically expressed in outer hair cells (OHCs) of the cochlea and is essential in auditory processing. It acts as a motor protein that converts auditory stimuli to length changes in outer hair cells. It is a bidirectional voltage-to-force converter which uses cytoplasmic anions as extrinsic voltage sensors. The anions are translocated across the membrane in response to changes in the transmembrane voltage. They move towards the extracellular surface following hyperpolarization, and towards the cytoplasmic side in response to depolarization. This translocation triggers conformational changes in the protein that alter its surface area in the plane of the plasma membrane. The area decreases when the anion is near the cytoplasmic face of the membrane (short state), and increases when the ion has crossed the membrane to the outer surface (long state). It acts as an incomplete transporter since it moves anions across the membrane, but does not allow the anions to dissociate and escape to the extracellular space. Salicylate, an inhibitor of outer hair cell motility, acts as competitive antagonist at the anion-binding site. Mutations in SLC26A5 have been associated with non-syndromic hearing loss.